JCR Pharmaceuticals Co.,Ltd. 4552Short Interest
Estimated short interest in JCR Pharmaceuticals Co.,Ltd. (4552) is 5.71% of shares outstanding as of 2026-10-01. Institutions holding 0.5% or more: Citigroup Global Markets Limited, GOLDMAN SACHS INTERNATIONAL, Barclays Capital Securities Ltd and 1 others.
Estimated short interest
5.7100%
▼0.0900%
Estimated position (shares)
7,460,204
As of 2026-10-01
Short sellers
9 firms
280 reports
Short Interest Trend By institution, % of shares outstanding
Estimated short interest, stacking the latest reported position of each short seller. The 5 largest current holders are shown in color and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Citigroup Global Markets Limited
- GOLDMAN SACHS INTERNATIONAL
- Barclays Capital Securities Ltd
- Morgan Stanley MUFG Securities Co., Ltd.
- UBS AG
- Others
5.7100%
Estimated short interest, 2026-10-01
Others1.47%
UBS AG0.49%
Morgan Stanley MUFG Securities Co., Ltd.0.68%
Barclays Capital Securities Ltd0.97%
GOLDMAN SACHS INTERNATIONAL1.01%
Citigroup Global Markets Limited1.09%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-09-29 | Citigroup Global Markets Limited | Position 1,424,443 shares | Ratio 1.0900% | ▼0.0301% | Holding |
| 2026-09-30 | GOLDMAN SACHS INTERNATIONAL | Position 1,312,781 shares | Ratio 1.0100% | ▲0.0300% | Holding |
| 2026-09-11 | Barclays Capital Securities Ltd | Position 1,269,956 shares | Ratio 0.9700% | ▼0.0401% | Holding |
| 2026-10-01 | Morgan Stanley MUFG Securities Co., Ltd. | Position 890,564 shares | Ratio 0.6800% | ▼0.0900% | Holding |
| 2025-09-18 | UBS AG | Position 637,721 shares | Ratio 0.4900% | ▼0.0101% | Below 0.5% |
| 2026-08-19 | MERRILL LYNCH INTERNATIONAL | Position 589,356 shares | Ratio 0.4500% | ▼0.0500% | Below 0.5% |
| 2024-09-03 | JPM Securities Japan Co Ltd. | Position 567,829 shares | Ratio 0.4300% | ▼0.1001% | Below 0.5% |
| 2026-02-05 | Nomura International plc | Position 531,954 shares | Ratio 0.4100% | ▼0.1301% | Below 0.5% |
| 2025-10-21 | Qube Research & Technologies Limited | Position 235,600 shares | Ratio 0.1800% | ▼0.3200% | Below 0.5% |
| 2025-02-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 0 shares | Ratio 0.0000% | ▼0.6000% | Closed |
Disclosure History 280 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-01 | Morgan Stanley MUFG Securities Co., Ltd. | Position 890,564 shares | Ratio 0.6800% | ▼0.0900% | — |
| 2026-09-30 | GOLDMAN SACHS INTERNATIONAL | Position 1,312,781 shares | Ratio 1.0100% | ▲0.0300% | — |
| 2026-09-29 | Citigroup Global Markets Limited | Position 1,424,443 shares | Ratio 1.0900% | ▼0.0301% | — |
| 2026-09-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,005,364 shares | Ratio 0.7700% | ▼0.1100% | — |
| 2026-09-14 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,151,264 shares | Ratio 0.8800% | ▼0.0700% | — |
| 2026-09-11 | Barclays Capital Securities Ltd | Position 1,269,956 shares | Ratio 0.9700% | ▼0.0401% | — |
| 2026-09-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,235,264 shares | Ratio 0.9500% | ▼0.0501% | — |
| 2026-09-10 | Citigroup Global Markets Limited | Position 1,454,243 shares | Ratio 1.1200% | ▲0.0600% | — |
| 2026-09-09 | Barclays Capital Securities Ltd | Position 1,312,500 shares | Ratio 1.0100% | ▲0.3200% | — |
| 2026-09-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,304,764 shares | Ratio 1.0000% | ▲0.2900% | — |
| 2026-09-04 | GOLDMAN SACHS INTERNATIONAL | Position 1,281,081 shares | Ratio 0.9800% | ▼0.1001% | — |
| 2026-09-04 | Barclays Capital Securities Ltd | Position 902,100 shares | Ratio 0.6900% | ▼0.0101% | — |
| 2026-09-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 926,664 shares | Ratio 0.7100% | ▲0.0999% | — |
| 2026-08-31 | Barclays Capital Securities Ltd | Position 908,900 shares | Ratio 0.7000% | ▲0.0299% | — |
| 2026-08-28 | Barclays Capital Securities Ltd | Position 877,000 shares | Ratio 0.6700% | ▼0.0500% | — |
| 2026-08-26 | GOLDMAN SACHS INTERNATIONAL | Position 1,413,081 shares | Ratio 1.0800% | ▼1.1000% | — |
| 2026-08-26 | Citigroup Global Markets Limited | Position 1,385,943 shares | Ratio 1.0600% | ▼0.1300% | — |
| 2026-08-26 | Barclays Capital Securities Ltd | Position 942,800 shares | Ratio 0.7200% | ▲0.0300% | — |
| 2026-08-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 791,864 shares | Ratio 0.6100% | ▲0.0799% | — |
| 2026-08-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 688,864 shares | Ratio 0.5300% | ▲0.0500% | — |
| 2026-08-19 | MERRILL LYNCH INTERNATIONAL | Position 589,356 shares | Ratio 0.4500% | ▼0.0500% | Below 0.5% |
| 2026-08-19 | Morgan Stanley MUFG Securities Co., Ltd. | Position 626,964 shares | Ratio 0.4800% | ▼0.0201% | Below 0.5% |
| 2026-08-17 | MERRILL LYNCH INTERNATIONAL | Position 657,456 shares | Ratio 0.5000% | ▲0.0100% | — |
| 2026-08-17 | GOLDMAN SACHS INTERNATIONAL | Position 2,839,381 shares | Ratio 2.1800% | ▼0.0300% | — |
| 2026-08-17 | Citigroup Global Markets Limited | Position 1,545,243 shares | Ratio 1.1900% | ▼0.0701% | — |
| 2026-08-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 659,064 shares | Ratio 0.5000% | ▲0.0900% | — |
| 2026-08-14 | GOLDMAN SACHS INTERNATIONAL | Position 2,866,881 shares | Ratio 2.2100% | ▲0.0200% | — |
| 2026-08-13 | MERRILL LYNCH INTERNATIONAL | Position 644,656 shares | Ratio 0.4900% | ▼0.0401% | Below 0.5% |
| 2026-08-13 | GOLDMAN SACHS INTERNATIONAL | Position 2,843,881 shares | Ratio 2.1900% | ▼0.1001% | — |
| 2026-08-13 | Citigroup Global Markets Limited | Position 1,646,943 shares | Ratio 1.2600% | ▼0.0401% | — |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |